Correlation Between Rapport Therapeutics, and Cars

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rapport Therapeutics, and Cars at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rapport Therapeutics, and Cars into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rapport Therapeutics, Common and Cars Inc, you can compare the effects of market volatilities on Rapport Therapeutics, and Cars and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rapport Therapeutics, with a short position of Cars. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rapport Therapeutics, and Cars.

Diversification Opportunities for Rapport Therapeutics, and Cars

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Rapport and Cars is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Rapport Therapeutics, Common and Cars Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cars Inc and Rapport Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rapport Therapeutics, Common are associated (or correlated) with Cars. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cars Inc has no effect on the direction of Rapport Therapeutics, i.e., Rapport Therapeutics, and Cars go up and down completely randomly.

Pair Corralation between Rapport Therapeutics, and Cars

Given the investment horizon of 90 days Rapport Therapeutics, Common is expected to under-perform the Cars. In addition to that, Rapport Therapeutics, is 3.02 times more volatile than Cars Inc. It trades about -0.22 of its total potential returns per unit of risk. Cars Inc is currently generating about 0.0 per unit of volatility. If you would invest  1,939  in Cars Inc on September 12, 2024 and sell it today you would lose (5.00) from holding Cars Inc or give up 0.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rapport Therapeutics, Common  vs.  Cars Inc

 Performance 
       Timeline  
Rapport Therapeutics, 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Rapport Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Rapport Therapeutics, reported solid returns over the last few months and may actually be approaching a breakup point.
Cars Inc 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cars Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Cars unveiled solid returns over the last few months and may actually be approaching a breakup point.

Rapport Therapeutics, and Cars Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rapport Therapeutics, and Cars

The main advantage of trading using opposite Rapport Therapeutics, and Cars positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rapport Therapeutics, position performs unexpectedly, Cars can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cars will offset losses from the drop in Cars' long position.
The idea behind Rapport Therapeutics, Common and Cars Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities